Growth hormone ameliorates adipose dysfunction during oxidative stress and inflammation and improves glucose tolerance in obese mice

Hormone and Metabolic Research

Volumn 46, Issue 9, 2014, Pages 656-662

  Fukushima, M ^a   Okamoto, Y ^a,b   Katsumata, H ^a   Ishikawa, M ^b   Ishii, S ^a   Okamoto, M ^a   Minami, S ^a,b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

adiponectin; adipose tissue; glucose tolerance; growth hormone; inflammation; oxidative stress

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CATALASE; CD206 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUCOSE; GLUTATHIONE PEROXIDASE; GROWTH HORMONE; HYDROGEN PEROXIDE; INSULIN; INTERLEUKIN 10; LEPTIN; LYMPHOCYTE ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; GLUCOSE BLOOD LEVEL; GROWTH HORMONE, BOVINE; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

3T3 CELL LINE; ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET; DIET RESTRICTION; EPIDIDYMIS FAT; FAT MASS; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HORMONAL THERAPY; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RELEASE; INTRAABDOMINAL FAT; LIPID PEROXIDATION; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT DURATION; ANIMAL; BOVINE; C57BL MOUSE; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

BOVINAE; MUS;

ADIPONECTIN; ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CATTLE; GLUCOSE INTOLERANCE; GROWTH HORMONE; HUMANS; INTERLEUKIN-10; LECTINS, C-TYPE; LEPTIN; MALE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OXIDATIVE STRESS; RECEPTORS, CELL SURFACE;

EID: 84906320614     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1381998     Document Type: Article

References (35)

1. Beshyah S. A., Freemantle C., Thomas E., Rutherford O., Page B., Murphy M., Johnston D. G. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults. Clin Endocrinol (Oxf): 1995; 42 179 189
2. Carroll P. V., Christ E. R., Bengtsson B. A., Carlsson L., Christiansen J. S., Clemmons D., Hintz R., Ho K., Laron Z., Sizonenko P., Sonksen P. H., Tanaka T., Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab: 1998; 83 382 395
3. Attanasio A. F., Bates P. C., Ho K. K., Webb S. M., Ross R. J., Strasburger C. J., Bouillon R., Crowe B., Selander K., Valle D., Lamberts S. W. Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status - 3-year results from the HypoCCS Database. J Clin Endocrinol Metab: 2002; 87 1600 1606
4. Hoffman A. R., Kuntze J. E., Baptista J., Baum H. B., Baumann G. P., Biller B. M., Clark R. V., Cook D., Inzucchi S. E., Kleinberg D., Klibanski A., Phillips L. S., Ridgway E. C., Robbins R. J., Schlechte J., Sharma M., Thorner M. O., Vance M. L. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. J Clin Endocrinol Metab: 2004; 89 2048 2056
5. Matsuzawa Y., Funahashi T., Nakamura T. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. J Atheroscler Thromb: 2011; 18 629 639
6. Kershaw E. E., Flier J. S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab: 2004; 89 2548 2556
7. Okamoto Y., Kihara S., Funahashi T., Matsuzawa Y., Libby P. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond): 2006; 110 267 278
8. Friedman J. M. Obesity: Causes and control of excess body fat. Nature: 2009; 459 340 342
9. Hotamisligil G. S. Inflammation and metabolic disorders. Nature: 2006; 444 860 867
10. Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M., Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest: 2004; 114 1752 1761
11. Wellen K. E., Hotamisligil G. S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest: 2003; 112 1785 1788
12. Wisse B. E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol: 2004; 15 2792 2800
13. Veldhuis J. D., Iranmanesh A., Ho K. K., Waters M. J., Johnson M. L., Lizarralde G. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab: 1991; 72 51 59
14. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes: 2003; 52 1655 1663
15. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes: 2001; 50 2094 2099
16. Kamada Y., Matsumoto H., Tamura S., Fukushima J., Kiso S., Fukui K., Igura T., Maeda N., Kihara S., Funahashi T., Matsuzawa Y., Shimomura I., Hayashi N. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J Hepatol: 2007; 47 556 564
17. Velloso C. P. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol: 2008; 154 557 568
18. Ding J., List E. O., Bower B. D., Kopchick J. J. Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome. Endocrinology: 2011; 152 3791 3802
19. Bielohuby M., Schaab M., Kummann M., Sawitzky M., Gebhardt R., Binder G., Frystyk J., Bjerre M., Hoeflich A., Kratzsch J., Bidlingmaier M. Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in mice. Endocrinology: 2011; 152 4764 4776
20. Lubbers E. R., List E. O., Jara A., Sackman-Sala L., Cordoba-Chacon J., Gahete M. D., Kineman R. D., Boparai R., Bartke A., Kopchick J. J., Berryman D. E. Adiponectin in mice with altered GH action: links to insulin sensitivity and longevity? J Endocrinol: 2013; 216 363 374
21. Xu H., Barnes G. T., Yang Q., Tan G., Yang D., Chou C. J., Sole J., Nichols A., Ross J. S., Tartaglia L. A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest: 2003; 112 1821 1830
22. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest: 2006; 116 1494 1505
23. Fujisaka S., Usui I., Bukhari A., Ikutani M., Oya T., Kanatani Y., Tsuneyama K., Nagai Y., Takatsu K., Urakaze M., Kobayashi M., Tobe K. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes: 2009; 58 2574 2582
24. Kumada M., Kihara S., Ouchi N., Kobayashi H., Okamoto Y., Ohashi K., Maeda K., Nagaretani H., Kishida K., Maeda N., Nagasawa A., Funahashi T., Matsuzawa Y. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation: 2004; 109 2046 2049
25. Ohashi K., Parker J. L., Ouchi N., Higuchi A., Vita J. A., Gokce N., Pedersen A. A., Kalthoff C., Tullin S., Sams A., Summer R., Walsh K. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. J Biol Chem: 2010; 285 6153 6160
26. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett: 2006; 580 2917 2921
27. Wu Y., Liu C., Sun H., Vijayakumar A., Giglou P. R., Qiao R., Oppenheimer J., Yakar S., LeRoith D. Growth hormone receptor regulates beta cell hyperplasia and glucose-stimulated insulin secretion in obese mice. J Clin Invest: 2011; 121 2422 2426
28. Vilar L., Naves L. A., Costa S. S., Abdalla L. F., Coelho C. E., Casulari L. A. Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly. Endocr Pract: 2007; 13 363 372
29. Colao A., Spinelli L., Cuocolo A., Spiezia S., Pivonello R., di Somma C., Bonaduce D., Salvatore M., Lombardi G. Cardiovascular consequences of early-onset growth hormone excess. J Clin Endocrinol Metab: 2002; 87 3097 3104
30. Frick F., Bohlooly-Y M., Lindén D., Olsson B., Törnell J., Edén S., Oscarsson J. Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice. Am J Physiol Endocrinol Metab: 2001; 281 E1230 E1239
31. Olsson B., Bohlooly-Y M., Fitzgerald S. M., Frick F., Ljungberg A., Ahrén B., Törnell J., Bergström G., Oscarsson J. Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology: 2005; 146 920 930
32. Moller N., Jorgensen J. O., Schmitz O., Moller J., Christiansen J., Alberti K. G., Orskov H. Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol: 1990; 258 E86 E91
33. Chen W., Hoo R. L., Konishi M., Itoh N., Lee P. C., Ye H. Y., Lam K. S., Xu A. Growth hormone induces hepatic production of fibroblast growth factor 21 through a mechanism dependent on lipolysis in adipocytes. J Biol Chem: 2011; 286 34559 34566
34. List E. O., Palmer A. J., Berryman D. E., Bower B., Kelder B., Kopchick J. J. Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of diet-induced obesity and type 2 diabetes. Diabetologia: 2009; 52 1647 1655
35. Minamino T., Orimo M., Shimizu I., Kunieda T., Yokoyama M., Ito T., Nojima A., Nabetani A., Oike Y., Matsubara H., Ishikawa F., Komuro I. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med: 2009; 15 1082 1087